1. Home
  2. PCRX vs VREX Comparison

PCRX vs VREX Comparison

Compare PCRX & VREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCRX
  • VREX
  • Stock Information
  • Founded
  • PCRX 2006
  • VREX 2016
  • Country
  • PCRX United States
  • VREX United States
  • Employees
  • PCRX N/A
  • VREX 2300
  • Industry
  • PCRX Biotechnology: Pharmaceutical Preparations
  • VREX Industrial Machinery/Components
  • Sector
  • PCRX Health Care
  • VREX Technology
  • Exchange
  • PCRX Nasdaq
  • VREX Nasdaq
  • Market Cap
  • PCRX 1.2B
  • VREX 576.8M
  • IPO Year
  • PCRX 2011
  • VREX N/A
  • Fundamental
  • Price
  • PCRX $26.59
  • VREX $14.15
  • Analyst Decision
  • PCRX Buy
  • VREX Strong Buy
  • Analyst Count
  • PCRX 10
  • VREX 1
  • Target Price
  • PCRX $29.30
  • VREX $21.00
  • AVG Volume (30 Days)
  • PCRX 892.8K
  • VREX 377.8K
  • Earning Date
  • PCRX 02-27-2025
  • VREX 02-06-2025
  • Dividend Yield
  • PCRX N/A
  • VREX N/A
  • EPS Growth
  • PCRX N/A
  • VREX N/A
  • EPS
  • PCRX N/A
  • VREX N/A
  • Revenue
  • PCRX $694,957,000.00
  • VREX $811,000,000.00
  • Revenue This Year
  • PCRX $5.14
  • VREX $3.50
  • Revenue Next Year
  • PCRX $2.44
  • VREX $3.37
  • P/E Ratio
  • PCRX N/A
  • VREX N/A
  • Revenue Growth
  • PCRX 4.40
  • VREX N/A
  • 52 Week Low
  • PCRX $11.16
  • VREX $10.19
  • 52 Week High
  • PCRX $31.67
  • VREX $19.91
  • Technical
  • Relative Strength Index (RSI)
  • PCRX 77.75
  • VREX 43.34
  • Support Level
  • PCRX $25.06
  • VREX $13.35
  • Resistance Level
  • PCRX $27.10
  • VREX $14.08
  • Average True Range (ATR)
  • PCRX 1.45
  • VREX 0.41
  • MACD
  • PCRX 0.28
  • VREX 0.03
  • Stochastic Oscillator
  • PCRX 86.23
  • VREX 23.89

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.

About VREX Varex Imaging Corporation

Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, digital detectors and accessories, generators, and heat exchangers among other products. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors, high-voltage connectors, and coolers. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA) and the rest from the Americas and Asia Pacific region.

Share on Social Networks: